Automated quantification of neuronal swellings in a preclinical rodent model of Parkinson’s disease detects region-specific changes in pathology

Chung, 2009, Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy, J. Neurosci., 29, 3365, 10.1523/JNEUROSCI.5427-08.2009 Davidsson, 2020, A comparison of AAV-vector production methods for gene therapy and preclinical assessment, Sci. Rep., 10, 21532, 10.1038/s41598-020-78521-w Decressac, 2012, Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson’s disease, Exp. Neurol., 235, 306, 10.1016/j.expneurol.2012.02.012 Decressac, 2012, Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons, Neurobiol. Dis., 45, 939, 10.1016/j.nbd.2011.12.013 Gubinelli, 2022, Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioural tests, Behav. Brain Res., 10.1016/j.bbr.2022.113887 Heuer, 2013, Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats, 247, 285 Kirik, 2002, Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system, J. Neurosci., 22, 2780, 10.1523/JNEUROSCI.22-07-02780.2002 Kneynsberg, 2016, Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures, J. Neurosci. Methods, 266, 32, 10.1016/j.jneumeth.2016.03.004 Kordower, 2013, Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease, Brain, 136, 2419, 10.1093/brain/awt192 Kurowska, 2016, Is axonal degeneration a key early event in Parkinson’s disease?, J. Park. Dis., 6, 703 Lo Bianco, 2002, alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s disease, Proc. Natl. Acad. Sci. U.S.A., 99, 10813, 10.1073/pnas.152339799 Lundblad, 2012, Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons, Proc. Natl. Acad. Sci. U.S.A., 109, 3213, 10.1073/pnas.1200575109 Marangoni, 2014, Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington’s disease, Neurobiol. Aging, 35, 2382, 10.1016/j.neurobiolaging.2014.04.024 Negrini, 2020, AAV production everywhere: a simple, fast, and reliable protocol for in-house AAV vector production based on chloroform extraction, Curr. Protoc. Neurosci., 93, 10.1002/cpns.103 Negrini, 2022, Sequential or simultaneous injection of preformed fibrils and AAV overexpression of alpha-synuclein are equipotent in producing relevant pathology and behavioral deficits, J. Park. Dis. Oliveras-Salva, 2013, rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration, Mol. Neurodegener., 8, 44, 10.1186/1750-1326-8-44 Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 Zhou, 1998, Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration, Ann. Neurol., 44, 99, 10.1002/ana.410440116